Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Function
Interventions: DRUG: Goserelin acetate
Sponsor: AstraZeneca